These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15847742)
1. [Pulmonary hemorrhage after abciximab. Risk factors and the role of protamine]. Rodríguez-Gómez FJ; Sánchez A; Martínez FJ; Andreu J; Alvarez A; Pujol E Rev Esp Cardiol; 2005 Apr; 58(4):453-5. PubMed ID: 15847742 [TBL] [Abstract][Full Text] [Related]
2. Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor. Sitges M; Villa FP Int J Cardiol; 1997 Dec; 62(3):269-71. PubMed ID: 9476687 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy. Choi RK; Lee NH; Lim DS; Hong Sk; Hwang HK Mayo Clin Proc; 2002 Dec; 77(12):1340-3. PubMed ID: 12479522 [TBL] [Abstract][Full Text] [Related]
4. Fatal pulmonary haemorrhage with the combined use of abciximab and fibrinolytic agent. Tan HC; Low A; Ng KS; Budiono B; Sutandar A; Chia BL; Lim YT Singapore Med J; 2002 Nov; 43(11):587-9. PubMed ID: 12680530 [TBL] [Abstract][Full Text] [Related]
5. Alveolar hemorrhage as a complication of treatment with abciximab. Kalra S; Bell MR; Rihal CS Chest; 2001 Jul; 120(1):126-31. PubMed ID: 11451827 [TBL] [Abstract][Full Text] [Related]
6. Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention. Conley M; Patino G; Romick B; Almaleh M; Campbell C; Hawkins K; Moore S; Allan P Can J Cardiol; 2008 Feb; 24(2):149-51. PubMed ID: 18273491 [TBL] [Abstract][Full Text] [Related]